From Surf Wiki (app.surf) — the open knowledge base
4-HO-MPMI
Chemical compound
Chemical compound
| elimination_half-life =
4-HO-MPMI, also known as 4-hydroxy-N-methyl-(α,N-trimethylene)tryptamine or as lucigenol, is a psychedelic drug of the pyrrolidinylmethylindole and cyclized tryptamine families.
Interactions
Pharmacology
Pharmacodynamics
The affinity (Ki) of 4-HO-MPMI for the serotonin 5-HT2A receptor has been found to be 13nM. It produces psychedelic-appropriate responding in animal tests with similar potency as DOI. The drug has two enantiomers, with only the (R)-enantiomer being active.
Chemistry
Analogues
Analogues of 4-HO-MPMI include MPMI, 5-MeO-MPMI, 5F-MPMI, CP-135,807, 4-HO-McPeT, 4-HO-pyr-T, and SN-22, among others.
History
4-HO-MPMI was developed by the team led by David E. Nichols from Purdue University in the late 1990s.
Society and culture
Legal status
Canada
4-HO-MPMI is not a controlled substance in Canada as of 2025.
References
References
- (1999). "Further studies on oxygenated tryptamines with LSD-like activity incorporating a chiral pyrrolidine moiety into the side chain". Journal of Medicinal Chemistry.
- "Controlled Drugs and Substances Act".
This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page.
Ask Mako anything about 4-HO-MPMI — get instant answers, deeper analysis, and related topics.
Research with MakoFree with your Surf account
Create a free account to save articles, ask Mako questions, and organize your research.
Sign up freeThis content may have been generated or modified by AI. CloudSurf Software LLC is not responsible for the accuracy, completeness, or reliability of AI-generated content. Always verify important information from primary sources.
Report